Barbara Mikulski actually said...

There is such compelling interest in this issue in Maryland from iconic institutions like Hopkins and the University of Maryland.

The FDA lacks authority to require notification from manufacturers when a plant shuts down, which could lead to a drug shortage.

I have heard from Maryland hospitals, doctors, nurses and patients that drug shortages are a serious problem with serious consequences.

I know the hour is late. This has been a very needed conversation and I look forward to reviewing the testimony.